Humana Inc. (HUM) — Fair Value Analysis

Base-case fair value (P50): $370.31 · Current price: $389.05 · Verdict: Fairly Valued

The Verdict on HUM

Our Monte Carlo simulations indicate Humana (HUM) is Fairly Valued at its current market price. While the stock trades at $389.05, our median fair value (P50) stands at $370.31, representing an -4.8% divergence. This narrow gap suggests the market has largely priced in the company's fundamentals as interpreted through our probabilistic modeling. Despite this alignment, HUM's operational and financial health is categorized as "weak" within the Healthcare sector, a factor that influences the overall fair value assessment and limits potential upside based on current projections.

How HUM stacks up against Healthcare

Humana's "weak" quality tier, derived from its operational and financial health relative to its Healthcare sector peers, introduces a layer of caution into its valuation. Even with this contextual backdrop, the Monte Carlo simulation, which accounts for various future scenarios, still points to a Fairly Valued status. The current price of $389.05 is closely tethered to the $370.31 fair value, with only an -4.8% difference, reinforcing that the market's perception aligns with our model's median outcome despite the underlying quality tier. This highlights the precise nature of the Monte Carlo output, which factors in a wide range of variables.

What this means for investors

For investors considering HUM, the Fairly Valued verdict signals that significant immediate upside or downside from the current $389.05 to the $370.31 fair value is unlikely, given the -4.8% difference. The "weak" quality tier, however, warrants attention for long-term strategic positioning within the Healthcare sector. While the market equilibrium appears stable, the underlying operational strength is a key consideration. To explore the full spectrum of possibilities for Humana, including comprehensive bear and bull case scenarios and the probability distribution of future outcomes, sign up for a free FairCurve account. You can also add HUM to your watchlist to track its fair value as new fundamentals are released.